TGCT1
MCID: TST046
MIFTS: 35

Testicular Germ Cell Tumor 1 (TGCT1)

Categories: Cancer diseases, Fetal diseases, Genetic diseases, Rare diseases, Reproductive diseases

Aliases & Classifications for Testicular Germ Cell Tumor 1

MalaCards integrated aliases for Testicular Germ Cell Tumor 1:

Name: Testicular Germ Cell Tumor 1 58 74
Testicular Germ Cell Tumor 58 74
Tgct1 58

Characteristics:

HPO:

33
testicular germ cell tumor 1:
Inheritance x-linked inheritance


Classifications:



External Ids:

OMIM 58 300228
MedGen 43 C1846164
SNOMED-CT via HPO 70 263934009

Summaries for Testicular Germ Cell Tumor 1

MalaCards based summary : Testicular Germ Cell Tumor 1, also known as testicular germ cell tumor, is related to testicular germ cell tumor and pediatric testicular germ cell tumor. An important gene associated with Testicular Germ Cell Tumor 1 is TGCT1 (Testicular Germ Cell Tumor Susceptibility 1). The drugs Carboplatin and Ifosfamide have been mentioned in the context of this disorder. Affiliated tissues include bone marrow, kidney and lymph node, and related phenotype is germ cell neoplasia.

Description from OMIM: 300228

Related Diseases for Testicular Germ Cell Tumor 1

Diseases in the Testicular Germ Cell Tumor family:

Testicular Germ Cell Tumor 1

Diseases related to Testicular Germ Cell Tumor 1 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 72)
# Related Disease Score Top Affiliating Genes
1 testicular germ cell tumor 12.9
2 pediatric testicular germ cell tumor 12.6
3 testicular germ cell tumor non-seminomatous 12.4
4 testicular germ cell cancer 12.0
5 pigmented villonodular synovitis 11.4
6 testicular seminoma 11.3
7 cone-rod dystrophy and hearing loss 2 11.1
8 germ cells tumors 11.1
9 seminoma 10.5
10 embryonal carcinoma 10.4
11 testicular microlithiasis 10.4
12 testicular cancer 10.3
13 choriocarcinoma 10.3
14 teratoma 10.3
15 wilms tumor 1 10.3
16 rhabdomyosarcoma 10.3
17 cryptorchidism, unilateral or bilateral 10.2
18 retinoblastoma 10.1
19 down syndrome 10.1
20 wilms tumor 5 10.1
21 wilms tumor 6 10.1
22 angiosarcoma 10.1
23 infant gynecomastia 10.1
24 gynecomastia 10.1
25 azoospermia 10.1
26 endodermal sinus tumor 10.1
27 germ cell cancer 10.1
28 mature teratoma 10.1
29 hydrocele 10.1
30 leukemia, acute monocytic 10.0
31 prostate cancer 10.0
32 small cell cancer of the lung 10.0
33 lung cancer 10.0
34 chondrosarcoma 10.0
35 indifference to pain, congenital, autosomal recessive 10.0
36 androgen insensitivity syndrome 10.0
37 prostate cancer, hereditary, 8 10.0
38 anxiety 10.0
39 prostate cancer, hereditary, 6 10.0
40 alpha-fetoprotein, hereditary persistence of 10.0
41 alopecia 10.0
42 leukemia 10.0
43 neutropenia 10.0
44 androgenic alopecia 10.0
45 thrombosis 10.0
46 desmoid tumor 10.0
47 sarcoma 10.0
48 allergic hypersensitivity disease 10.0
49 splenic infarction 10.0
50 cystic teratoma 10.0

Graphical network of the top 20 diseases related to Testicular Germ Cell Tumor 1:



Diseases related to Testicular Germ Cell Tumor 1

Symptoms & Phenotypes for Testicular Germ Cell Tumor 1

Human phenotypes related to Testicular Germ Cell Tumor 1:

33
# Description HPO Frequency HPO Source Accession
1 germ cell neoplasia 33 HP:0100728

Clinical features from OMIM:

300228

Drugs & Therapeutics for Testicular Germ Cell Tumor 1

Drugs for Testicular Germ Cell Tumor 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 246)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Carboplatin Approved Phase 3,Phase 2,Phase 1,Not Applicable 41575-94-4 10339178 38904 498142
2
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
3
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1,Not Applicable 50-18-0, 6055-19-2 2907
4
Etoposide Approved Phase 3,Phase 2,Phase 1,Not Applicable 33419-42-0 36462
5
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
6
Vinblastine Approved Phase 3 865-21-4 241903 13342
7
Granisetron Approved, Investigational Phase 3,Not Applicable 109889-09-0 3510
8
Mechlorethamine Approved, Investigational Phase 3,Phase 1,Phase 2,Not Applicable 51-75-2 4033
9
Bleomycin Approved, Investigational Phase 3,Phase 2,Not Applicable 11056-06-7 5360373
10
Paclitaxel Approved, Vet_approved Phase 3,Phase 2,Phase 1,Not Applicable 33069-62-4 36314
11
Oxaliplatin Approved, Investigational Phase 3,Phase 2 61825-94-3 43805 6857599 5310940 9887054
12
Lenograstim Approved, Investigational Phase 2, Phase 3,Phase 3,Phase 1 135968-09-1
13
Levofloxacin Approved, Investigational Phase 3 100986-85-4 149096
14
Ofloxacin Approved Phase 3 82419-36-1 4583
15
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
16
Captopril Approved Phase 3 62571-86-2 44093
17
Ribavirin Approved Phase 3 36791-04-5 37542
18
Palivizumab Approved, Investigational Phase 3 188039-54-5
19
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
20
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2,Not Applicable 22916-47-8 4189
21
Itraconazole Approved, Investigational Phase 3,Not Applicable 84625-61-6 55283
22
Caspofungin Approved Phase 3,Phase 2 162808-62-0, 179463-17-3 2826718 468682
23
Amphotericin B Approved, Investigational Phase 3 1397-89-3 5280965 14956
24
Acyclovir Approved Phase 3 59277-89-3 2022
25
Moxifloxacin Approved, Investigational Phase 3 354812-41-2, 151096-09-2 152946
26
Norgestimate Approved, Investigational Phase 3 35189-28-7 6540478
27
Ethinyl Estradiol Approved Phase 3 57-63-6 5991
28
Polyestradiol phosphate Approved Phase 3 28014-46-2
29
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757
30
Histamine Approved, Investigational Phase 3 51-45-6 774
31
Cyproheptadine Approved Phase 3 129-03-3 2913
32
Mycophenolic acid Approved Phase 3 24280-93-1 446541
33
Calcium Approved, Nutraceutical Phase 3,Phase 2,Not Applicable 7440-70-2 271
34 Pancreatic Polypeptide Investigational Phase 3,Phase 1 59763-91-6
35 Antimitotic Agents Phase 3,Phase 2,Phase 1,Not Applicable
36 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1,Not Applicable
37
Isophosphamide mustard Phase 3,Phase 2,Phase 1 0
38 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1,Not Applicable
39 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1,Not Applicable
40 Etoposide phosphate Phase 3,Phase 2,Phase 1,Not Applicable
41 Alkylating Agents Phase 3,Phase 2,Phase 1,Not Applicable
42 Immunosuppressive Agents Phase 3,Phase 1,Phase 2,Not Applicable
43 Antirheumatic Agents Phase 3,Phase 2,Phase 1,Not Applicable
44 Immunologic Factors Phase 3,Phase 1,Phase 2,Not Applicable
45 Serotonin Antagonists Phase 3,Phase 2,Not Applicable
46 Antiemetics Phase 3,Phase 2,Not Applicable
47 Serotonin Agents Phase 3,Phase 2,Not Applicable
48 Neurotransmitter Agents Phase 3,Phase 2,Not Applicable
49 Gastrointestinal Agents Phase 3,Phase 2,Not Applicable
50 Autonomic Agents Phase 3,Phase 2,Not Applicable

Interventional clinical trials:

(show top 50) (show all 156)
# Name Status NCT ID Phase Drugs
1 Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the Testicle Unknown status NCT00589537 Phase 3
2 Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors Unknown status NCT00002566 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide;ifosfamide;vinblastine sulfate
3 Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma Unknown status NCT00004219 Phase 3 granisetron hydrochloride;lerisetron
4 Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors Unknown status NCT00104676 Phase 3 cisplatin;etoposide;ifosfamide;oxaliplatin;paclitaxel
5 Combination Chemotherapy in Treating Men With Germ Cell Cancer Unknown status NCT00003643 Phase 2, Phase 3 cisplatin;etoposide;paclitaxel
6 Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer Unknown status NCT01087268 Phase 3
7 Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors Unknown status NCT00274950 Phase 3 carboplatin;cisplatin;etoposide;ifosfamide;vinblastine sulfate
8 Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer Completed NCT00003014 Phase 3 carboplatin
9 Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles Completed NCT00324298 Phase 3 cisplatin;etoposide
10 Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors Completed NCT00002596 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide
11 Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer Completed NCT00003941 Phase 3 cisplatin;etoposide;ifosfamide
12 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00005590 Phase 3 levofloxacin
13 Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors Completed NCT00053352 Phase 3 cisplatin;etoposide
14 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
15 Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Completed NCT01305200 Phase 3 supersaturated calcium phosphate rinse
16 Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant Completed NCT00305851 Phase 3
17 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
18 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3 ribavirin
19 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3 fluconazole;itraconazole
20 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
21 Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation Completed NCT00045292 Phase 3 acyclovir;acyclovir sodium;valacyclovir
22 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
23 Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Completed NCT00716976 Phase 3 sodium thiosulfate
24 Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors Terminated NCT00072215 Phase 3 cisplatin;ifosfamide;paclitaxel;vinblastine
25 Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant Terminated NCT00324324 Phase 3 moxifloxacin hydrochloride;Placebo
26 Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Terminated NCT01132547 Phase 3 cyproheptadine hydrochloride
27 Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD) Terminated NCT00089141 Phase 3 mycophenolate mofetil;placebo
28 High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy Unknown status NCT01172912 Phase 2 carboplatin;cisplatin;dexamethasone;etoposide;ifosfamide
29 Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors Unknown status NCT00551122 Phase 1, Phase 2 cisplatin;gemcitabine hydrochloride;ifosfamide;paclitaxel
30 Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin Completed NCT00002559 Phase 1, Phase 2 cisplatin;ifosfamide;paclitaxel
31 Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors Completed NCT00301782 Phase 2 carboplatin;cisplatin;etoposide phosphate;vincristine sulfate
32 Arsenic Trioxide in Treating Men With Germ Cell Cancer Completed NCT00036842 Phase 2 arsenic trioxide
33 Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer Completed NCT00004077 Phase 2 cisplatin;ifosfamide;paclitaxel
34 Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors Completed NCT00003518 Phase 2 gemcitabine hydrochloride;paclitaxel
35 Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin Completed NCT00006043 Phase 2 temozolomide
36 Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors Completed NCT00002508 Phase 1, Phase 2 carboplatin;etoposide
37 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors Completed NCT00002558 Phase 1, Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel
38 Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer Completed NCT00002903 Phase 2 docetaxel
39 Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors Completed NCT00453232 Phase 2 cisplatin;etoposide
40 Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer Completed NCT00002943 Phase 2 carboplatin;cyclophosphamide;etoposide
41 Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment Completed NCT00453310 Phase 2 sunitinib malate
42 Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors Completed NCT00070096 Phase 2 ixabepilone
43 Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors Completed NCT00470366 Phase 2 cisplatin;ifosfamide;paclitaxel
44 Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin Completed NCT00423852 Phase 1, Phase 2 carboplatin;ifosfamide;paclitaxel
45 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer Completed NCT00002931 Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel
46 Avelumab in Refractory Testicular Germ Cell Cancer. Completed NCT03403777 Phase 2 Avelumab
47 High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors Completed NCT00003173 Phase 2 thiotepa
48 Campath-1H + FK506 and Methylprednisolone for GVHD Completed NCT00109993 Phase 2 methylprednisolone;tacrolimus
49 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00003887 Phase 2
50 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate

Search NIH Clinical Center for Testicular Germ Cell Tumor 1

Genetic Tests for Testicular Germ Cell Tumor 1

Anatomical Context for Testicular Germ Cell Tumor 1

MalaCards organs/tissues related to Testicular Germ Cell Tumor 1:

42
Bone Marrow, Kidney, Lymph Node, Small Intestine, Monocytes, Brain, Colon

Publications for Testicular Germ Cell Tumor 1

Articles related to Testicular Germ Cell Tumor 1:

(show top 50) (show all 213)
# Title Authors Year
1
Cytokeratin 7, inhibin, and p63 in testicular germ cell tumor: superior markers of choriocarcinoma compared to β-human chorionic gonadotropin. ( 30359635 )
2019
2
Is gynecomastia related to the disease characteristics and prognosis in testicular germ cell tumor patients? ( 31063146 )
2019
3
Seminoma component of mixed testicular germ cell tumor shows a higher incidence of loss of heterozygosity than pure-type seminoma. ( 30266250 )
2019
4
Association between male pattern baldness and testicular germ cell tumor: a meta-analysis. ( 30634927 )
2019
5
Spontaneous regression as a 'burned-out' non-seminomatous testicular germ cell tumor: a case report and literature review. ( 30647899 )
2019
6
Testicular germ cell tumor: a comprehensive review. ( 30671589 )
2019
7
Association between androgen receptor gene polymorphisms and testicular germ cell tumor: A systematic review and meta-analysis. ( 30900623 )
2019
8
Comprehensive characterization of cancer-testis genes in testicular germ cell tumor. ( 31070303 )
2019
9
Testicular Germ Cell Tumor Showing Concurrent PNET and Neuroglial Neoplasms With Wide Spectrum of Grades. ( 31091205 )
2019
10
Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis. ( 29529997 )
2018
11
Mature Cystic Teratoma of the Lung With a Somatic-Like Malignant Component in a Patient With Testicular Germ-Cell Tumor. ( 30041955 )
2018
12
Distinct telomere length and molecular signatures in seminoma and non-seminoma of testicular germ cell tumor. ( 29579225 )
2018
13
Cutaneous Presentation of a Testicular Germ Cell Tumor With Seminomatous Differentiation. ( 28452794 )
2018
14
Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors. ( 29352051 )
2018
15
Increased risk of testis failure in testicular germ cell tumor survivors undergoing radiotherapy. ( 29423028 )
2018
16
Prime evidence for testicular germ cell tumor initiation. ( 29545287 )
2018
17
Characteristics, treatment decisions and outcomes of prepubertal testicular germ cell tumor: A descriptive analysis from a large Chinese center. ( 29705139 )
2018
18
Re: Identification of 19 New Risk Loci and Potential Regulatory Mechanisms Influencing Susceptibility to Testicular Germ Cell Tumor. ( 30227584 )
2018
19
A miR-125b/CSF1-CX3CL1/tumor-associated macrophage recruitment axis controls testicular germ cell tumor growth. ( 30237497 )
2018
20
MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients. ( 30321995 )
2018
21
Clinicopathological Significance and Antitumor Effect of MPHOSPH1 in Testicular Germ Cell Tumor. ( 30519350 )
2018
22
Novel association of familial testicular germ cell tumor and autosomal dominant polycystic kidney disease with PKD1 mutation. ( 27577987 )
2017
23
Testicular germ cell tumor genomics. ( 27584029 )
2017
24
A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor. ( 27754579 )
2017
25
More Cases of Benign Testicular Teratomas are Detected in Adults than in Children. A Clinicopathological Study of 543 Testicular Germ Cell Tumor Cases. ( 27796764 )
2017
26
Plasma Cytokines Correlated With Disease Characteristics, Progression-Free Survival, and Overall Survival in Testicular Germ-Cell Tumor Patients. ( 28237180 )
2017
27
Future of testicular germ cell tumor incidence in the United States: Forecast through 2026. ( 28241106 )
2017
28
Antioxidant enzyme profile and lipid peroxidation products in semen samples of testicular germ cell tumor patients submitted to orchiectomy. ( 28266817 )
2017
29
Mosaic chromosome Y loss and testicular germ cell tumor risk. ( 28275244 )
2017
30
Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor. ( 28604728 )
2017
31
Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor. ( 28604732 )
2017
32
Editorial Comment: Antioxidant enzyme profile and lipid peroxidation products in semen samples of testicular germ cell tumor patients submitted to orchiectomy. ( 28783265 )
2017
33
Association Between RASSF1A Promoter Methylation and Testicular Germ Cell Tumor: A Meta-analysis and a Cohort Study. ( 28871003 )
2017
34
MGMT and CALCA promoter methylation are associated with poor prognosis in testicular germ cell tumor patients. ( 28881587 )
2017
35
Bilateral methachronous testicular germ cell tumor and testicular microlithiasis in a child: Genetic analysis and insights. A case report. ( 29040905 )
2017
36
Gastrointestinal Involvement of Testicular Germ Cell Tumor: A Case Report and Literature Review. ( 29130004 )
2017
37
Anxiety and depression in long-term testicular germ cell tumor survivors. ( 26439320 )
2016
38
Long-term Relative Survival after Diagnosis of Testicular Germ Cell Tumor. ( 26908435 )
2016
39
DNA methyltransferase-3 like protein expression in various histological types of testicular germ cell tumor. ( 26917601 )
2016
40
Right Cardiac Chambers Involvement by a Malignant Testicular Germ Cell Tumor: An Imaging-pathologic Correlation. ( 27017904 )
2016
41
Familial testicular germ cell tumor with bilateral disease. ( 27072274 )
2016
42
Crosstalk between Meg3 and miR-1297 regulates growth of testicular germ cell tumor through PTEN/PI3K/AKT pathway. ( 27158395 )
2016
43
Brain Metastases as Presenting Feature in 'Burned Out' Testicular Germ Cell Tumor. ( 27182465 )
2016
44
A rare cause in etiology of left atrial mass: metastatic testicular germ cell tumor. ( 27212979 )
2016
45
Identifying functional cancer-specific miRNA-mRNA interactions in testicular germ cell tumor. ( 27235586 )
2016
46
Impact of Bep or Carboplatin Chemotherapy on Testicular Function and Sperm Nucleus of Subjects with Testicular Germ Cell Tumor. ( 27242529 )
2016
47
Does the Serum Metallothionein Level Reflect the Stage of Testicular Germ Cell Tumor? ( 27255355 )
2016
48
Consumption of alcoholic beverages in adolescence and adulthood and risk of testicular germ cell tumor. ( 27474852 )
2016
49
Testicular germ cell tumor: Short and long-term side effects of treatment among survivors. ( 27588190 )
2016
50
Prognostic value of serum carbonic anhydrase IX in testicular germ cell tumor patients. ( 27698832 )
2016

Variations for Testicular Germ Cell Tumor 1

Expression for Testicular Germ Cell Tumor 1

Search GEO for disease gene expression data for Testicular Germ Cell Tumor 1.

Pathways for Testicular Germ Cell Tumor 1

GO Terms for Testicular Germ Cell Tumor 1

Sources for Testicular Germ Cell Tumor 1

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....